Elizabeth Cohen-Jonathan-Moyal

TL;DR: The European Association for Neuro-Oncology guideline provides recommendations for the clinical care of adult patients with astrocytic and oligodendroglial gliomas, including glioblastomas, based on the 2016 WHO classification of tumours of the central nervous system and on scientific developments since the 2014 guideline.

TL;DR: This guideline provides recommendations for diagnostic and therapeutic procedures for patients with malignant gliomas and contributes to a critical appreciation of concurrent drugs with a focus on the controlled use of anticonvulsants and steroids.

TL;DR: Advanced magnetic resonance imaging techniques such as diffusion-weighted imaging, perfusion MRI, and proton magnetic resonance spectroscopic imaging are more efficient than conventional MRI in differentiating pseudoprogression from true progression (TP).

TL;DR: The results suggest that blocking GPM6A or PTPRZ1 could represent an interesting approach in the treatment of glioblastoma since it would simultaneously target proliferation, invasion, and radioresistance.